Knockdown of LMO1 in JURKAT cells and of LMO2 in MOLT-14 cells resulted in reduced expression of LMO1/2 and NKX3-1, confirming the activatory impact of LMO proteins in TAL1 positive T-ALL cells (Fig. 3D). The gene discussed is TAL1; the disease is acute lymphoblastic leukemia.